Search in:

Future Science OA Volume 8, 2022 - Issue 3

Submit an article Journal homepage

Open access

3,300

Views

CrossRef citations to date

Altmetric

Review

Kinesin Spindle Protein Inhibitors in Cancer: From High Throughput Screening to Novel Therapeutic Strategies

Rand Shahin1 he Hashemite University, Faculty of Pharmaceutical Sciences, Department of Pharmaceutical Chemistry, P.O. Box 330127, Al-Zarqa, 13133, JordanCorrespondence[email protected]

https://orcid.org/0000-0001-7330-4433

Salah Aljamal2 Faculty of pharmacy, University of Jordan, Amman, 11942, Jordan

https://orcid.org/0000-0003-1514-8772

Article: FSO778 | Received 23 Sep 2021, Accepted 14 Dec 2021, Published online: 21 Feb 2022

Cite this article
https://doi.org/10.2144/fsoa-2021-0116
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (14)

Guoyuan Tang, Shan Huang, Ji Luo, Yingmiao Wu, Shuai Zheng, Rongsheng Tong, Ling Zhong & Jianyou Shi. (2023) Advances in research on potential inhibitors of multiple myeloma. European Journal of Medicinal Chemistry 262, pages 115875.
Crossref

Tao Chen, Yunqian Chu, Haiyuan Xu, Hanjue Dai, Yuxi ZhouHaiwei DuWenyu Zhu. (2023) Kinesin superfamily member KIFC2 as an independent prognostic biomarker of colon adenocarcinoma associated with poor immune response. Medicine 102:43, pages e35491.
Crossref

Soumya M. Turaga, Vikalp Vishwakarma, Stacey L. Hembruff, Benjamin K. Gibbs, Priya Sabu, Rajni V. Puri, Harsh B. Pathak, Glenson Samuel & Andrew K. Godwin. (2023) Inducing Mitotic Catastrophe as a Therapeutic Approach to Improve Outcomes in Ewing Sarcoma. Cancers 15:20, pages 4911.
Crossref

Yiquan Li, Zihao Wang, Yuchao Dong, Xiaoyang Yu, Jing Lu, Ningyi Jin, Chao Shang, Xiao Li & Shiyong Fan. (2023) A novel antibody-KSP inhibitor conjugate improves KSP inhibitor efficacy in vitro and in vivo. Biomaterials 301, pages 122258.
Crossref

Danyang Zheng, Chenqi Yang, Xiaogang Li, Dong Liu, Yan Wang, Xuesong Wang, Xueying Zhang, Yinfeng Tan, Yuchen Zhang, Youbin Li & Junyu Xu. (2023) Design, Synthesis, Antitumour Evaluation, and In Silico Studies of Pyrazolo-[1,5-c]quinazolinone Derivatives Targeting Potential Cyclin-Dependent Kinases. Molecules 28:18, pages 6606.
Crossref

Karolina Kowalczyk, Andrzej Błauż, Daniel Moscoh Ayine‐Tora, Christian G. Hartinger, Błażej Rychlik & Damian Plażuk. (2023) Design, Synthesis, and Evaluation of Biological Activity of Ferrocene‐Ispinesib Hybrids: Impact of a Ferrocenyl Group on the Antiproliferative and Kinesin Spindle Protein Inhibitory Activity. Chemistry – A European Journal 29:49.
Crossref

Michał Łomzik, Andrzej Błauż, Marta Głodek, Anna Makal, Daniel Tchoń, Daniel Moscoh Ayine-Tora, Christian Hartinger, Błażej Rychlik & Damian Plażuk. (2023) Organometallic Ru, Os, Rh and Ir half-sandwich conjugates of ispinesib – impact of the organometallic group on the antimitotic activity. Dalton Transactions 52:34, pages 11859-11874.
Crossref

Muhammad Tufail. (2023) DNA repair pathways in breast cancer: from mechanisms to clinical applications. Breast Cancer Research and Treatment 200:3, pages 305-321.
Crossref

John C. Smith, Stefan Husted, Jay Pilrose, Stephanie C. Ems-McClung, Jane R. Stout, Richard L. Carpenter & Claire E. Walczak. (2023) MCAK Inhibitors Induce Aneuploidy in Triple-Negative Breast Cancer Models. Cancers 15:13, pages 3309.
Crossref

Hanley N. Abramson. (2023) Recent Advances in the Applications of Small Molecules in the Treatment of Multiple Myeloma. International Journal of Molecular Sciences 24:3, pages 2645.
Crossref

Adrian D. Hobson. 2023. 1 59 .

Fatimah Jan, Benu Chaudhary, Anshul Chawla, Syed Ovais, Saima Mushtaq & Adil Farooq Wali. 2023. Dihydropyrimidinones as Potent Anticancer Agents. Dihydropyrimidinones as Potent Anticancer Agents 223 .

Dhirajkumar Nikam & Anurekha Jain. (2022) Advances in the discovery of DHPMs as Eg5 inhibitors for the management of breast cancer and glioblastoma: A review. Results in Chemistry, pages 100718.
Crossref

Rana M. El-Masry, Basma M. Essa, Adli A. Selim, Soad Z. El-Emam, Khaled O. Mohamed, Tamer M. Sakr, Hanan H. Kadry, Azza T. Taher & Sahar M. Abou-Seri. (2022) New 5-Aryl-1,3,4-Thiadiazole-Based Anticancer Agents: Design, Synthesis, In Vitro Biological Evaluation and In Vivo Radioactive Tracing Studies. Pharmaceuticals 15:12, pages 1476.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Kinesin Spindle Protein Inhibitors in Cancer: From High Throughput Screening to Novel Therapeutic Strategies

Articles from other publishers (14)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Kinesin Spindle Protein Inhibitors in Cancer: From High Throughput Screening to Novel Therapeutic Strategies

Citations (14)

Articles from other publishers (14)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date